Ewha Med J.  2022 Jan;45(1):25-27. 10.12771/emj.2022.45.1.25.

Stereotactic Radiosurgery for Metastatic Brain Tumor: What Should We Think a Little More about?

• Yang NR

• KMID: 2525292
• DOI: http://doi.org/10.12771/emj.2022.45.1.25

Abstract

no abstract available.

Reference

1. Kim YG. 2021; Stereotactic radiosurgery for metastatic brain tumor. Ewha Med J. 44:103–110. DOI: 10.12771/emj.2021.44.4.103.

2. Rastogi K, Bhaskar S, Gupta S, Jain S, Singh D, Kumar P. 2018; Palliation of brain metastases: analysis of prognostic factors affecting overall survival. Indian J Palliat Care. 24:308–312. DOI: 10.4103/IJPC.IJPC_1_18. PMID: 30111944. PMCID: PMC6069611.

3. Mulvenna P, Nankivell M, Barton R, Faivre-Finn C, Wilson P, McColl E, et al. 2016; Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet. 388:2004–2014. DOI: 10.1016/S0140-6736(16)30825-X. PMID: 27604504. PMCID: PMC5082599.

4. Pinkham MB, Sanghera P, Wall GK, Dawson BD, Whitfield GA. 2015; Neurocognitive effects following cranial irradiation for brain metastases. Clin Oncol (R Coll Radiol). 27:630–639. DOI: 10.1016/j.clon.2015.06.005. PMID: 26119727.

5. Park K, Bae GH, Kim WK, Yoo CJ, Park CW, Kim SK, et al. 2021; Radiotherapy for brain metastasis and long-term survival. Sci Rep. 11:8046. DOI: 10.1038/s41598-021-87357-x. PMID: 33850188. PMCID: PMC8044241.

6. Chang EL, Selek U, Hassenbusch SJ 3rd, Maor MH, Allen PK, Mahajan A, et al. 2005; Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery. Neurosurgery. 56:936–945. PMID: 15854241.

7. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, et al. 2000; Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 47:291–298. DOI: 10.1016/S0360-3016(99)00507-6. PMID: 10802351.

8. Yomo S, Hayashi M. 2012; Fatal tumoral hemorrhage after stereotactic radiosurgery for metastatic brain tumors: report of three cases and review of literature. Acta Neurochir (Wien). 154:1685–1690. DOI: 10.1007/s00701-012-1447-5. PMID: 22821090.

9. Sayan M, Sahin B, Mustafayev TZ, Kefelioglu ESS, Vergalasova I, Gupta A, et al. 2021; Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases. Neurocirugia (Astur : Engl Ed). 32:261–267. DOI: 10.1016/j.neucir.2020.08.009. PMID: 33082103.

10. Lanier CM, Lecompte M, Glenn C, Hughes RT, Isom S, Jenkins W, et al. 2021; A single-institution retrospective study of patients treated with laser-interstitial thermal therapy for radiation necrosis of the brain. Cureus. 13:e19967. DOI: 10.7759/cureus.19967. PMID: 34984127. PMCID: PMC8714182.

11. Karschnia P, Le Rhun E, Vogelbaum MA, van den Bent M, Grau SJ, Preusser M, et al. 2021; The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy. Eur J Cancer. 156:93–108. DOI: 10.1016/j.ejca.2021.07.032. PMID: 34425408.